For example, GFAP and NfL, when combined with established risk factors like age, sex, and ApoE ξ4, show strong discriminatory power in distinguishing amyloid-positive from amyloid-negative individuals, facilitating more precise diagnostic pathways for AD [6]. This evidence concerns the gene GFAP and Alzheimer disease.